Oral pilocarpine for radiation-induced xerostomia: Integrated efficacy and safety results from two prospective randomized clinical trials

International Journal of Radiation Oncology, Biology, Physics

Volumn 31, Issue 3, 1995, Pages 661-669

  Rieke, John W ^a   Hafermann, Mark D ^a   Johnson, Jonas T ^b   LeVeque, Francis G ^b   Iwamoto, Ryan ^a   Steiger, Barry W ^c   Muscoplat, Charles ^d   Gallagher, Susan C ^d  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

^b University of Pittsburgh School of Medicine   (United States)

^c HARPER UNIVERSITY HOSPITAL   (United States)

^d GUILFORD PHARMACEUTICALS INC   (United States)

Author keywords

Efficacy; Head and neck cancer; Multicenter trials; Pilocarpine; Radiation; Safety; Xerostomia

Indexed keywords

PILOCARPINE; SALIVA SUBSTITUTE;

ADULT; AGED; ARTICLE; ASTHENIA; CANCER RADIOTHERAPY; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEAD AND NECK CANCER; HUMAN; HYPERHIDROSIS; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; SALIVATION; VERTIGO; XEROSTOMIA;

ADMINISTRATION, ORAL; ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PILOCARPINE; RADIOTHERAPY; XEROSTOMIA;

EID: 0028857470     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(94)00361-N     Document Type: Article

References (27)

1. Therapy-induced dysfunction of salivary glands: Implications for oral health
2. A clinical test for parotid function
3. The composition of human saliva secreted in response to a gustatory stimulus and top pilocarpine
4. Clinical and material sciences: Prevention of xerostomia-related dental caries in irradiated cancer patients
5. The effect of irradiation in high doses on parotid glands
6. Effect of fractionated radiotherapy on salivary gland function
7. Preirradiation qualities of a parotid gland predicting the grade of functional disturbance by radiotherapy
8. Synergistic effect of sialogogues in management of xerostomia after radiation therapy
9. Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia)
10. Treatment of salivary gland hypofunction with sustained-release pilocarpine HCl
11. Pilocarpine for the treatment of xerostomia associated with salivary gland dysfunction
12. Acquired dental defects and salivary gland lesions after irradiation for carcinoma
13. The use of pilocarpine in postradiation xerostomia
14. Effectiveness of pilocarpine in postradiation xerostomia
15. Oral pilocarpine for postirradiation xerostomia in patients with head and neck cancer
16. A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients
17. Effect of pilocarpine and a beta-adrenergic blocking agent on human saliva
18. The effect of pharmacological agents on salivary secretion and composition in man. I. Pilocarpine, atropine and anticholinesterases
19. The aetiology of xerostomia (dry mouth)
20. Therapeutic radiology—the modalities and their effects on oral tissues
21. Treatment of radiation side effects with oral pilocarpine
22. Effect of radiotherapy on whole saliva flow
23. Radiosensitivity of the human parotid gland (#39988)
24. Radiation effects
25. Radiation therapy of oral carcinoma: I. Effects on oral tissues and management of the periodontium
26. Xerostomia: A neglected symptom
27. Xerostomia treatment using pilocarpine